Literature DB >> 6967438

Abnormal regulation of immunoglobulin synthesis in vitro in primary biliary cirrhosis.

S P James, C O Elson, E A Jones, W Strober.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6967438

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  25 in total

1.  Methylprednisolone administration in primary biliary cirrhosis increases cholic acid turnover, synthesis, and deoxycholate concentration in bile.

Authors:  G Mazzella; P Fusaroli; A Pezzoli; F Azzaroli; C Mazzeo; L Zambonin; P Simoni; D Festi; E Roda
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

Review 2.  Primary biliary cirrhosis.

Authors:  J Neuberger; M Lombard; R Galbraith
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 3.  Primary biliary cirrhosis: considerations on pathogenesis based on identification of the M2 autoantigens.

Authors:  I R Mackay; M E Gershwin
Journal:  Springer Semin Immunopathol       Date:  1990

4.  HLA-DR antigens in primary biliary cirrhosis: lack of association.

Authors:  M F Bassendine; P J Dewar; O F James
Journal:  Gut       Date:  1985-06       Impact factor: 23.059

5.  T-lymphocyte subsets in liver tissues of patients with primary biliary cirrhosis (PBC), patients with primary sclerosing cholangitis (PSC), and normal controls.

Authors:  L Si; T L Whiteside; R R Schade; T E Starzl; D H Van Thiel
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

6.  Immunoglobulin secretion in human disease states.

Authors:  M G Beale; R P MacDermott
Journal:  Surv Immunol Res       Date:  1983

7.  Polyclonal B cell activation in alcoholic patients with no evidence of liver dysfunction.

Authors:  P A Drew; P M Clifton; J T LaBrooy; D J Shearman
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

8.  Loss of suppressor T-cells in active inflammatory bowel disease.

Authors:  N J Godin; D B Sachar; R Winchester; C Simon; H D Janowitz
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

9.  In vitro correction of a deficiency of Con A-induced suppressor cell function in primary biliary cirrhosis by a pharmacological concentration of colchicine.

Authors:  D Ilfeld; E Theodor; G Delpre; O Kuperman
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

10.  Demonstration of non-specific B-cell stimulation in patients with cirrhosis.

Authors:  G Holdstock; W B Ershler; E L Krawitt
Journal:  Gut       Date:  1982-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.